Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 241 AL 255

Home-Based, Virtually Supervised Combined Exercise Intervention in People With Parkinson Disease: Protocol for a Randomized Controlled Trial

Mehta N, Munoz MJ, Allen IE, Tanner CM, Corcos DM, Luthra NS.

JMIR Res Protoc. 2026 Jun 30;15:e97507. doi: 10.2196/97507.

Large-scale functional annotation establishes a reference framework for human LRRK2 variants

Cheung A, Pratuseviciute N, Black K, Lis P, Phung T, Cavin M, Morel G, Saari A, Huin V, Zittel-Dirks S, Tonelli F, Riebenbauer B, Gasser T, Ruiz-Martinez J; Global Parkinson’s Genetics Program (GP2); Morris HR, Lange LM, Dilliott A, Goldstein O, Shani S, Arnaud L, Zimprich A, Pirker W, Klein C, Alcalay R, Lohmann K, Alessi DR, Sammler E.

medRxiv [Preprint]. 2026 Jun 26:2026.06.17.26355034. doi: 10.64898/2026.06.17.26355034.

Fiber Tractography-Guided MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease: A Case Report

Hori H, Hori T, Taira T.

Cureus. 2026 Jun 3;18(6):e110159. doi: 10.7759/cureus.110159. eCollection 2026 Jun.

Artificial Intelligence That Changes Clinical Neurology Practice: Translating Algorithms Into Actionable Care

Kim Y, Choe SA, Jeong S, Jie D, Wang X, Lee H, Kim BJ.

J Clin Neurol. 2026 Jul;22(4):392-407. doi: 10.3988/jcn.2026.0312.

Advanced MRI for targeting the pallidothalamic region in magnetic resonance-guided focused ultrasound: the mammillothalamic tract as an adjacent imaging landmark

Rivera F, Quintanal Cordero N, Piedimonte F.

Front Radiol. 2026 Jun 24;6:1856951. doi: 10.3389/fradi.2026.1856951. eCollection 2026.

Glucagon-like peptide-1 agonists in Parkinson's disease: a meta-analysis

Abdallah AK, Harb A, Mansour A, Nasreldin A, Hamdy R, Hatem N, Mosad N, Hamouda M, Hamouda A, Arumaithurai K.

Neurol Sci. 2026 Jul 11;47(8):620. doi: 10.1007/s10072-026-09238-3.

Top-Cited Articles on Dysphagia and Cognitive Impairment: A Scopus-Based Bibliometric Analysis of Publications Retrieved Through October 2025

Montúffar-Otero NV, Gómez-Coello A, Murphy P, Murillo-Chavez AA, Roldan-Valadez E.

Cureus. 2026 Jun 10;18(6):e110620. doi: 10.7759/cureus.110620. eCollection 2026 Jun.

Parkinson's disease across female reproductive stages: Clinical implications from menstruation to menopause

Boone DL, Borges V, Ferraz HB.

Parkinsonism Relat Disord. 2026 Jul 9:108420. doi: 10.1016/j.parkreldis.2026.108420. Online ahead of print.

Narrative Review of Body-First Versus Brain-First Prodromal Neuropsychiatric Symptoms in Parkinson's Disease

Mohammed SF, Goyal A, Kakde SP, Mishra AP, Ashok Kumar AK, Chepng'eno Koske D, Imam B, Abraham J, Cruz JRR, Jacob AM, Majji S, Aswathappa S.

Cureus. 2026 Jun 6;18(6):e110371. doi: 10.7759/cureus.110371. eCollection 2026 Jun.

Comparison of Anatomical Landmarks and Atlas- and Automated Atlas Segmentation Application-Based Targeting in Magnetic Resonance Imaging-Guided Focused Ultrasound Ventralis Intermedius Thalamotomy

Osakada Y, Hirabayashi H, Fukutome K, Sato N, Ikawa K, Morihara R, Yamashita T, Ishiura H, Kuga Y, Ohnishi H, Ohnishi H.

Oper Neurosurg. 2026 Aug 1;31(2):309-318. doi: 10.1227/ons.0000000000001828. Epub 2025 Nov 10.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial

Fernandez HH, Bhatia P, Cloud L, Fietzek UM, Matarazzo M, Molho E, Peckham E, Tarakad A, Combs C, Leoni M, Chang I, Tringali S, Boiser J, Sanchez R, Zadikoff C.

Lancet Neurol. 2026 Aug;25(8):721-730. doi: 10.1016/S1474-4422(26)00215-2.

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications

Lange LM, Fang ZH, Makarious MB, Kuznetsov N, Atterling Brolin K, Ballard S, Bardien S, Doquenia ML, Heutink P, Houlden H, Iwaki H, Jasaityte S, Jones L, Junker J, Kaiyrzhanov R, Koretsky MJ, Kumar KR; Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD); Leonard HL, Levine KS, Lim SY, Mencacci NE, Mohamed WMY, Nalls MA, Noyce AJ, Ojha R, Okubadejo NU, Ur Rehman S, Screven L, Shashkin C, Sopromadze S, Stafford EJ, Tan AH, Tan M, Tavadyan Z, Trinh J, Tserensodnom B, Valente EM, Vitale D, Zharkinbekova N, Lohmann K, Bandres-Ciga S, Blauwendraat C, Singleton AB, Morris HR, Klein C; Global Parkinson's Genetics Program (GP2).

Lancet Neurol. 2026 Aug;25(8):741-754. doi: 10.1016/S1474-4422(26)00198-5.

Artificial intelligence in deep brain stimulation for movement disorders: a systematic review and technology readiness assessment

Souei Z, Mushhood Ur Rehman M, Akram H, Bloch J, Chabardes S, Fasano A, Hariz M, Krauss JK, Kühn AA, Limousin P, Lumsden DE, Moraud EM, Moro E, Reich MM, Zrinzo L, Vasques X, Cif L.

NPJ Digit Med. 2026 Jul 16. doi: 10.1038/s41746-026-03015-4. Online ahead of print.

Clinical outcomes at 6 months after MRgFUS thalamotomy in Parkinson's disease: a large longitudinal cohort study

Pistoia F, Salfi F, Arrigoni F, Saporito G, Bruno F, Catalucci A, Pistoia ML, Cesarano S, Sacco S, Splendiani A, Sucapane P.

J Neurol. 2026 Jul 26;273(8):492. doi: 10.1007/s00415-026-14021-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias